# Silvergate Pharmaceuticals, Inc.: Form D filings

Silvergate Pharmaceuticals, Inc., a pharmaceuticals company in Greenwood Village, CO, filed 5 Form D notices with the SEC between 2011 and 2016. The latest, on October 18, 2016, reports $4.6 million sold of a $4.6 million offering to 10 investors.

Find out what Silvergate Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Silvergate%20Pharmaceuticals%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Silvergate%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsilvergate-pharmaceuticals-inc-1520642)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Silvergate%20Pharmaceuticals%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Silvergate%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsilvergate-pharmaceuticals-inc-1520642)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Colorado](https://specstream.ai/data/form-d/state/colorado): 1,787 rows, by operating companies, filed since November 1, 2024, $89.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/colorado
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 6251 GREENWOOD PLAZA BOULEVARD, SUITE 101, Greenwood Village, CO, 80111
- Phone: (720) 266-4524
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1520642

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 18, 2016 | New notice | $4,600,000 | $4,600,000 | $0 | 10 | Oct 3, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1520642/000152064216000002/0001520642-16-000002-index.htm) |
| Oct 14, 2015 | New notice | $4,600,000 | $1,600,000 | $3,000,000 | 9 | Oct 9, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1520642/000152064215000001/0001520642-15-000001-index.htm) |
| Sep 12, 2014 | New notice | $1,000,000 | $1,000,000 | $0 | 7 | Aug 28, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1520642/000152064214000001/0001520642-14-000001-index.htm) |
| Jun 14, 2013 | Amendment | $23,554,167 | $23,554,167 | $0 | 13 | May 2, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1520642/000152064213000002/0001520642-13-000002-index.htm) |
| May 17, 2011 | New notice | $3,015,000 | $3,015,000 | $0 | 2 | May 2, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1520642/000152064211000001/0001520642-11-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Bhaskar Chaundhuri | Director |  |
| Barry Barnard | Executive Officer |  |
| Laura Medina | Executive Officer |  |
| Frank Segrave | Executive Officer, Director |  |
| Robert Mauro | Executive Officer |  |
| Mark Parrish | Director |  |
| Patrick Heron | Director |  |
| Nathan Every | Director |  |
| Michael Beckloff | Executive Officer |  |

[Every Form D from the week of Oct 17, 2016](https://specstream.ai/data/form-d/week/2016-10-17) · [All recent filings in Colorado](https://specstream.ai/data/form-d/state/colorado) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Silvergate Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).